BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37719007)

  • 21. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docetaxel-loaded PLGA nanoparticles to increase pharmacological sensitivity in MDA-MB-231 and MCF-7 breast cancer cells.
    Tran P; Nguyen TN; Lee Y; Tran PN; Park JS
    Korean J Physiol Pharmacol; 2021 Sep; 25(5):479-488. PubMed ID: 34448465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer.
    Cabeza L; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Jiménez-López J; Perazzoli G; Martin-Banderas L; Baeyens JM; Melguizo C; Prados J
    Bioimpacts; 2022; 12(6):515-531. PubMed ID: 36644541
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticancer mechanism of 7-α-hydroxyfrullanolide on microtubules and computational prediction of its target binding in triple-negative breast cancer cells.
    Chimplee S; Smythe C; Tipmanee V; Sukrong S; Kanokwiroon K
    PeerJ; 2022; 10():e13508. PubMed ID: 35651747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of LC-Q-TOF-MS/MS, network pharmacology, and nanoemulsion approaches identifies active compounds of two Artemisia species responsible for tackling early diabetes-related metabolic complications in the liver.
    Moulahoum H; Ghorbanizamani F; Khiari Z; Toumi M; Benazzoug Y; Timur S; Zihnioglu F
    Phytochem Anal; 2022 Oct; 33(7):1058-1067. PubMed ID: 35795911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of Fibulin-2 expression with proliferation, migration and invasion of breast cancer cells.
    Zhang X; Duan L; Zhang Y; Zhao H; Yang X; Zhang C
    Oncol Lett; 2020 Aug; 20(2):1945-1951. PubMed ID: 32724439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
    Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
    J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.
    Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
    Döhr O; Vogel C; Abel J
    Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perturbation of tubulin structure by stellate gold nanoparticles retards MDA-MB-231 breast cancer cell viability.
    Nirmala JG; Beck A; Mehta S; Lopus M
    J Biol Inorg Chem; 2019 Oct; 24(7):999-1007. PubMed ID: 31388822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
    Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
    Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a PCR High-Resolution Melt Assay for Artemisia absinthium (Wormwood) and a Triplex Assay with Two Additional "Unregulated Legal High" Species Datura stramonium (Jimson Weed) and Merremia tuberosa (Hawaiian Woodrose).
    Kiesel BD; Elkins KM
    J Forensic Sci; 2019 Nov; 64(6):1817-1822. PubMed ID: 31157922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo.
    Haggag YA; Matchett KB; Falconer RA; Isreb M; Jones J; Faheem A; McCarron P; El-Tanani M
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30769871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
    Xu J; Zuo D; Qi H; Shen Q; Bai Z; Han M; Li Z; Zhang W; Wu Y
    Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neomenthol prevents the proliferation of skin cancer cells by restraining tubulin polymerization and hyaluronidase activity.
    Fatima K; Masood N; Ahmad Wani Z; Meena A; Luqman S
    J Adv Res; 2021 Dec; 34():93-107. PubMed ID: 35024183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of
    Bagheri F; Amri J; Salehi M; Karami H; Alimoradian A; Latifi SA
    Horm Mol Biol Clin Investig; 2020 Oct; 41(4):. PubMed ID: 33079704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.
    Sana S; Tokala R; Bajaj DM; Nagesh N; Bokara KK; Kiranmai G; Lakshmi UJ; Vadlamani S; Talla V; Shankaraiah N
    Bioorg Chem; 2019 Dec; 93():103317. PubMed ID: 31586714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.